AD researchers may be interested to attend the Alzheimer’s Drug Discovery Foundation’s 9th annual conference in San Diego on March 1-3, 2015: Drug Discovery for Neurodegeneration Conference: An Intensive Course on Translating Research into Drugs The Alzheimer’s Drug Discovery Foundation explains: “This annual meeting provides an invaluable resource to the neurodegenerative disease community, bringing together […]
CONTINUE READINGThe November 2014 edition of Living Well A-Z in the Arizona Republic features an article highlighting several Arizona Alzheimer’s Consortium members. Click here to read the November 2014 Living Well A-Z (article starts on page 6).
CONTINUE READINGTGen’s online cognitive study MindCrowd will be featured on an upcoming episode of STEM Journals on Sunday, September 21st at 7pm on Cox 7 or 1007. MindCrowd is the first research project of its kind. Researchers hope that a million people worldwide will spend 10 minutes taking their online test. With the knowledge they glean from the results, scientists hope […]
CONTINUE READINGNew discoveries that may increase the effectiveness of Alzheimer’s treatments will be the topic at a Discovery Series presentation at the Biodesign Institute at ASU on Wednesday, Sept. 10 at 10 a.m. Genentech neuroscientist Ryan Watts, PhD, will discuss his work on a process that enables Alzheimer’s drugs to cross the blood-brain barrier, a challenge […]
CONTINUE READINGThe Department of Defense Peer Reviewed Alzheimer Research Program has new information available about research funding opportunities and its program goals for the future. This unique research program provides funding to address the long-term consequences of traumatic brain injury as they pertain to Alzheimer¹s disease (AD). Learn more at website: http://cdmrp.army.mil/prarp/default.shtml. Initially the program began with Congressional directed funding […]
CONTINUE READINGThe University of Arizona has received a $5 million gift for its McKnight Brain Institute that challenges other philanthropists to match the amount to help support ongoing funding for neuroscience research. Click here to read the full article.
CONTINUE READINGBrain imaging study examines three levels of risk for Alzheimer’s disease Phoenix (August 6, 2014) – The National Institutes of Health (NIH) renewed funding for the Banner Alzheimer’s Institute (BAI) and Mayo Clinic, Phoenix, longitudinal study of the earliest changes associated with the risk of developing Alzheimer’s disease at older ages. The award, an estimated […]
CONTINUE READINGTwo drugs to be studied in North America and Europe in volunteers at high risk for disease Copenhagen, Denmark (July 15, 2014) —Researchers from the Banner Alzheimer’s Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs—an active immunotherapy and an oral medication—can prevent or […]
CONTINUE READING7/15/14 A Phoenix-area research group (Banner Alzheimer’s Institute and its research partners) will team with Swiss pharmaceutical company Novartis to test two experimental drugs that aim to fend off Alzheimer’s disease in older adults who are at high risk but have not yet shown memory or thinking problems. Click here to read the full article.
CONTINUE READINGDr. Carol Barnes has been recognized by the American Psychological Association as a 2014 Distinguished Scientific Contribution award recipient. The award recognizes senior scientists for distinguished theoretical or empirical contributions to basic research in psychology. Dr. Barnes will be presented the award at the APA convention to be held August 7-10 in Washington, D.C. http://uaatwork.arizona.edu/lqp/carol-barnes-recognized-american-psychological-association-major-scientific-contributions?utm_source=lqp&utm_medium=email&utm_campaign=weekly_lqp%3E
CONTINUE READING